Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis

US10551345B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10551345-B2
Application numberUS-201715595439-A
CountryUS
Kind codeB2
Filing dateMay 15, 2017
Priority dateMay 15, 2003
Publication dateFeb 4, 2020
Grant dateFeb 4, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates generally to polymers and copolymers comprising N-vinylamide-type monomers, their preparation, and compositions, such as electrophoresis separation media, containing the same; to supports, such as capillaries, containing these polymers; and methods for separating a mixture of biomolecules, especially polynucleotides, using capillary electrophoresis. Separation media comprising such polymers yield advantageous performance in the analysis and separation of biomolecules by capillary electrophoresis.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising a buffer and a polymer having the form poly(M 1 x M 2 Y ), or a salt thereof, comprising one or more monomers of type M1 and optionally one or more monomers of type M 2 , wherein: (a) each monomer in the polymer is of type M 1 or M 2 ; (b) x is an integer ranging from 1 to 5 and represents the number of monomer subtypes of type M 1 that are present in the polymer; (c) y is an integer ranging from 0 to 5 and represents the number of monomer subtypes of type M 2 that are present in the polymer; (d) each monomer subtype of type M 1 in the polymer is independently: N-vinylformamide, N-vinylacetamide, N-vinylpropamide, N-vinylbutamide, N-vinylpentamide, N-vinylhexamide, N-vinylheptamide, N-vinyloctamide, N-vinylnonamide, N-vinyldecamide, N-methyl-N-vinylformamide, N-methyl-N-vinylacetamide, N-methyl-N-vinylpropamide, N-methyl-N-vinylbutamide, N-methyl-N-vinylpentamide, N-methyl-N-vinylhexamide, N-methyl-N-vinylheptamide, N-methyl-N-vinyloctamide, N-methyl-N-vinylnonamide, N-methyl-N-vinyldecamide, N-ethyl-N-vinylformamide, N-ethyl-N-vinylacetamide, N-ethyl-N-vinylpropamide, N-ethyl-N-vinylbutamide, N-ethyl-N-vinylpentamide, N-ethyl-N-vinylhexamide, N-ethyl-N-vinylheptamide, N-ethyl-N-vinyloctamide, N-ethyl-N-vinylnonamide, N-ethyl-N-vinyldecamide, N-n-propyl-N-vinylformamide, N-n-propyl-N-vinylacetamide, N-n-propyl-N-vinyl propamide, N-n-propyl-N-vinylbutamide, N-n-propyl-N-vinylpentamide, N-n-propyl-N-vinylhexamide, N-n-propyl-N-vinylheptamide, N-n-propyl-N-vinyloctamide, N-n-propyl-N-vinylnonamide, N-n-propyl-N-vinyldecamide, N-iso-propyl-N-vinylformamide, N-iso-propyl-N-vinylacetamide, N-iso-propyl-N-vinylpropamide, N-iso-propyl-N-vinylbutamide, N-iso-propyl-N-vinylpentamide, N-iso-propyl-N-vinylhexamide, N-iso-propyl-N-vinylheptamide, N-isa-propyl-N-vinyloctamide, N-iso-propyl-N-vinylnonamide or N-iso-propyl-N-vinyldecamide; (e) when y is not zero, each monomer subtype of type M 2 in the polymer is independently: N-hydroxy-acrylamide, N-methoxy-acrylamide, acryloyl urea, 1-vinyl-pyrrolidine-2,5-dione, 3-vinyl -oxazolidin-2-one, 1-vinyl-imidazolidin-2-one, 4-vinyl-morpholin-3,5-dione, 4-vinyl-morpholin-3-one, 4-vinyl-morpholine, 2-vinyl-1,3-dioxolane, 2-vinylene carbonate, methoxyethylene, vinyl acetate, vinyl alcohol, acrylamide, N-acetamido-acrylamide, N-acetyl-acrylamide, N-allyl-acrylamide, N-2-aminoethyl-acrylamide hydrochloride, N-2-aminoethyl-N-methyl -acrylamide hydrochloride, N-3-aminopropyl-acrylamide hydrochloride, N-3-aminopropyl-N-methyl-aerylamide hydrochloride, N-butoxymethyl-acrylamide, N-n-butyl-acrylamide, N-tert-butyl-acrylamide, N-2-cyanoethyl-acrylamide, N-cyanomethyl-acrylamide, N-cyanomethyl-N-methyl-acrylamide, N,N-diallyl-acrylamide, N,N-diethyl-acrylamide, N,N-diisopropyl-acrylamide, N,N-dimethyl-acrylamide, N-ethyl-N-methyl-acrylamide, N-ethyl-N-propyl-acrylamide, N-2-glycolic acid-acrylamide, N-2-glycolic acid methyl ester-acrylamide, N-2-hydroxyethyl-acrylamide, N-2-hydroxyethyl-N-methyl-acrylamide, N-hydroxymethyl-acrylamide, N-hydroxymethyl-N-methyl-acrylamide, N-iso-propyl-acrylamide, N-2-methoxyethyl-acrylamide, N-methoxymethyl-acrylamide, N-methyl-acrylamide, N-2,2,2-trichloro-1-hydroxyethyl-acrylamide, N-tri(hydroxymethyl)methyl-acrylamide, N-tri(hydroxymethyl)methyl-N-methyl-acrylamide, N-3-(trimethylammonium)propyl-acrylamide hydrochloride, N-3-(trimethylammonium)propyl-N-methyl-acrylamide hydrochloride, methacrylamide, N-acetamido-methacrylamide, N-acetyl-methacrylamide, N-allyl-methacrylamide, N-2-aminoethyl-methacrylamide hydrochloride, N-3-aminopropyl-methacrylamide hydrochloride, N-butoxymethyl-methacrylamide, N-n-butyl-methacrylamide, N-tert-butyl-methacrylamide, N-2-cyanoethyl-methacrylamide, N-cyanomethyl-methacrylamide, N-cyanomethyl-N-methyl-methacrylamide, N,N-diethyl-methacrylamide, N,N-dimethyl-methacrylamide, N-2-glycolic acid-methacrylamide, N-2-hydroxyethyl-methacrylamide, N-hydroxymethyl-methacrylamide, N-hydroxymethyl-N-methyl-methacrylamide, N-iso-propyl-methacrylamide, N-2-methoxethyl-methacrylamide, N-methoxymethyl-methacrylamide, N-methyl-methacrylamide, N-tri(hydroxymethyl)methyl-methacrylamide, N-3-(trimethylammonium)propyl-methacrylamide hydrochloride, or a mixture thereof; and (f). further comprises an effective amount of a sieve and/or EOF suppressing polymer comprising a monomer unit that is acrylamide, N-acetyl-acrylamide, N-2-cyanoethyl-acrylamide, N,N-1,2-dihydroxyethylene-bis-acrylamide, N- 4,4-dimethoxybutyl-acrylamide, N-2,2-dimethoxyethyl-acrylamide, N,N-dimethyl-acrylamide, N-2-glycolic acid methyl ester acrylamide, N-2-hydroxyethyl-acrylamide, N-hydroxymethyl-acrylamide, N-methoxymethyl-acrylamide, N-3-methoxypropyl-acrylamide, N-methyl-acrylamide, N-methyl-, N-2,2-dimethoxyethyl-acrylamide, N-morpholinoethyl-acrylamide, N-2,2,2-trichloro-1-hydroxyethyl-acrylamide, N-tri(hydroxymethyl)-methyl-acrylamide, methacrylamide, N-acetyl-methacrylamide, N-2-cyanoethyl-methacrylamide, N,N-1,2-dihydroxyethylene-bis-methacrylamide, N-4,4-dimethoxybutyl-methacrylamide, N-2,2-dimethoxyethyl-methacrylamide, N,N-dimethyl-methacrylamide, N-2-glycolic acid methyl ester methacrylamide, N-2-hydroxyethyl-methacrylamide, N-hydroxymethyl-methacrylamide, N-methoxymethyl-methacrylamide, N-3-methoxypropyl-methacrylamide, N-methyl-methacrylamide, N-methyl-, N-2,2-dimethoxyethyl-methacrylamide, N-morpholinoethyl-methacrylamide, N-2,2,2-trichloro-l-hydroxyethyl-methacrylamide, N-tri(hydroxymethyl)-methyl-methacrylamide, or a mixture thereof. 2. The composition of claim 1 , wherein the sieve and/or EOF suppressing polymer monomer unit is acrylamide. 3. The composition of claim 1 , which further comprises an effective amount of a sieve and/or EOF suppressing polymer which comprises or is poly(hydroxymethylene), poly(oxyethylene), poly(oxypropylene), poly(oxyethylene-co-oxypropylene), poly(vinylalcohol), poly(vinylpyrrolidone), poly(-ethyl-2-oxazoline), poly(-methyl-2-oxazoline), poly ((2-ethyl-2-oxazoline)-co-(2-methyl-2-oxazoline)), poly(N-acetamidoacrylamide), poly(acryloxylurea), hydroxyethyl cellulose, hydroxymethyl cellulose, or a mixture thereof. 4. The composition of claim 1 , wherein the polymer has a weight-average molecular weight of from about 150,000 Daltons to about 20 MDaltons. 5. The composition of claim 4 , which further comprises an effective amount of a sieve and/or EOF suppressing polymer having a weight-average molecular weight of from about 1 MDalton to about 5 MDaltons. 6. The composition of claim 5 , wherein the sieve and/or EOF suppressing polymer is substantially linear polyacrylamide. 7. The composition of claim 1 , wherein the composition is an aqueous composition. 8. The composition of claim 7 , wherein the composition has a pH of from about 5 to about 11. 9. The composition of claim 8 , further comprising formamide, urea, pyrrolidone, N-methyl pyrrolidone, or a mixture thereof. 10. The composition of claim 9 , further comprising urea. 11. The composition of claim 9 , further comprising formamide. 12. The composition of claim 7 , wherein the composition has a pH of from bout 7 to about 10. 13. The composition of claim 7 , wherein y is 0 and each M1 is independently N-vinylformamide or N-methyl-N-vinylacetamide. 14. The composition of claim 1 , wherein the composition is a dry composition. 15. The composition of claim 14 , wherein the composition has a pH of from about 5 to about 11. 16. The composition of claim 15 , further comprising formamide, urea, pyrrolidone, N-methyl pyrrolidone, or a mixture thereof. 17. The composition of claim 16 , further comprising urea.

Assignees

Inventors

Classifications

  • Composition of gel or of carrier mixture · CPC title

  • Controlling the zeta potential, e.g. by wall coatings · CPC title

  • Amides {, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide} · CPC title

  • Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen · CPC title

  • C08F26/00Primary

    Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10551345B2 cover?
The invention relates generally to polymers and copolymers comprising N-vinylamide-type monomers, their preparation, and compositions, such as electrophoresis separation media, containing the same; to supports, such as capillaries, containing these polymers; and methods for separating a mixture of biomolecules, especially polynucleotides, using capillary electrophoresis. Separation media compri…
Who is the assignee on this patent?
Applied Biosystems Llc
What technology area does this patent fall under?
Primary CPC classification G01N27/44747. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).